News

In an intriguing development, a study published in Biosensors and Bioelectronics suggests that honeybees might play a ...
Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy.
The public was unaware that Charles’ grandfather, King George VI, had lung cancer before his death in February 1952 at the age of 56. Some historians suggest that even the king wasn't told about ...
Scientists at the Cancer Research Manchester Institute have created a new model of Lung Squamous Cell Carcinoma (LUSC), a common type of lung cancer, to study the development, activity, and ...
1University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.
The province's health minister says P.E.I. is getting a lung cancer screening program, something advocates have said is urgently needed on the Island. "We have a two-year plan to phase in the ...
than other chemotherapeutic drugs in the treatment of non - small cell lung cancer, and it has been cited as many as 143 times. The article “A phase 3 trial of pirfenidone in patients with idiopathic ...
Method: We retrospectively evaluated the safety and efficacy of neoantigen peptide-pulsed dendritic cell (Neo-P DC) vaccine therapy after surgical treatment of pancreatic cancer. Result: The result ...
The diagnosis was lung cancer, leading to surgery to remove a tumor. Understandably, it led Williams to worry about how much time she had left. "It was concerning. I did kind of think about what ...
When you have lung cancer, you may notice that it even seems to affect your mouth. It could be drier, or more sensitive, or painful, or have sores. Food might not even taste the way it usually does.
BioN­Tech has high­ly en­cour­ag­ing sur­vival da­ta for its bis­pe­cif­ic an­ti­body com­bin­ing check­point block­ade with VEGF-A in­hi­bi­tion as a first-line treat­ment for ...
BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese ...